How GLP-1 Drugs and a Revamp Revived Ro’s Business
The telehealth company said that its annualized revenue had grown more than tenfold since it revamped its business and embraced weight-loss treatments.
Full story
Read the full story at The New York Times - Business ↗
Continue reading this story on The New York Times - Business, the publisher that reported it.
AI tools
Written by AI from the article text. It can make mistakes; check the original story.
